QR-koda

Exploratory Retrospective Assessment of Patients with Psoriasis Receiving Biological Therapy

<i>Background and Objectives</i>: Biological therapies improve disease severity and quality of life in patients with psoriasis, but data on Romanian patients remain limited. Our study aimed to characterize patients with psoriasis from Transylvania and to evaluate the impact of biologics on disease s...

Olles dieđut

Furkejuvvon:
Váldodahkkit: Andrada-Luciana Lazar, Sorana D. Bolboacă, Adrian-Lucian Baican, Corina-Iulia Baican, Sorina Dănescu, Elisabeta Candrea, Diana Valentina Câmpean, Paula Iluț, Ioana Semenescu, Adela-Viviana Sitar-Tăut, Romana Vulturar, Olga Hilda Orășan, Angela Cozma
Materiálatiipa: Artigo
Giella:Inglês
Almmustuhtton: MDPI AG 2026-01-01
Ráidu:Medicina
Fáttát:
psoriasis
Anti-Interleukin 17 biological therapy (anti-IL-17)
Anti-Interleukin 23 biological therapy (anti-IL-23)
Anti-Tumor Necrosis Factor biological therapy (anti-TNF)
Psoriasis Area Severity Index (PASI)
Dermatology Life Quality Index (DLQI)
Liŋkkat:https://www.mdpi.com/1648-9144/62/2/257
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid